3 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow Neoplasm Malignant: new trials by email Literature Review of Neoplasm Malignant trials Research Report on Neoplasm Malignant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors STRO-002 - Neoplasm Malignant | Phase 1 / Phase 2 | Completed | Tasly Pharmaceutical Group Co., Ltd | 19 | 2023-11-08 | 2026-04-06 |
| A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification SAR125844 - Neoplasm Malignant | Phase 2 | Completed | Sanofi | 1 | 2015-11-01 | 2016-03-23 |
| Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen SAR245408, SAR245409 - Neoplasm Malignant | Phase 1 / Phase 2 | Completed | Sanofi | 61 | 2012-07-20 | 2022-04-19 |
Neoplasms (3)
SAR125844 (1) · XL147 (1) · XL765 (1)
Sanofi (2) · Tasly Pharmaceutical Group Co., Ltd (1)
Belgium (2) · China (1) · France (1) · Spain (1) · United States (1)
2014 (1)